PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
48.17
+2.90 (6.41%)
At close: Aug 13, 2025, 4:00 PM
47.51
-0.66 (-1.37%)
Pre-market: Aug 14, 2025, 8:53 AM EDT
PTC Therapeutics Stock Forecast
Stock Price Forecast
According to 14 professional analysts, the 12-month price target for PTC Therapeutics stock ranges from a low of $42 to a high of $120. The average analyst price target of $68.07 forecasts a 41.31% increase in the stock price over the next year.
Price Target: $68.07 (+41.31%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PTC Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 13 | 13 | 13 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $60 → $63 | Buy | Maintains | $60 → $63 | +30.79% | Aug 8, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $78 → $79 | Buy | Maintains | $78 → $79 | +64.00% | Aug 8, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $80 → $86 | Strong Buy | Maintains | $80 → $86 | +78.53% | Jul 29, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $68 → $84 | Strong Buy | Maintains | $68 → $84 | +74.38% | Jul 29, 2025 |
| Barclays | Barclays | Hold Maintains $42 → $46 | Hold | Maintains | $42 → $46 | -4.50% | Jul 29, 2025 |
Financial Forecast
Revenue This Year
1.78B
from 806.78M
Increased by 120.38%
Revenue Next Year
883.92M
from 1.78B
Decreased by -50.29%
EPS This Year
6.92
from -4.73
EPS Next Year
-2.65
from 6.92
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.9B | 1.3B | 2.3B |
| Avg | 1.8B | 883.9M | 1.2B |
| Low | 1.6B | 678.0M | 816.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 140.5% | -27.1% | 158.3% |
| Avg | 120.4% | -50.3% | 30.4% |
| Low | 103.6% | -61.9% | -7.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.57 | 0.81 | 2.07 | ||
| Avg | 6.92 | -2.65 | -0.85 | ||
| Low | -3.12 | -5.43 | -4.17 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | -88.3% | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.